Search
for
Sort by
Research 30 of 60
- Pregnancy and the Skin
- Multiple minute digitate hyperkeratosis
- Dermatological manifestations associated with pregnancy
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Leflunomide-Induced Cutaneous Ulcers: A Rare Diagnostic Conundrum
- Teriflunomide in multiple sclerosis: an update
- Drug-induced changes in hair growth
- Westwood Carolina Conference on Clinical Dermatology
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Dermatoses of pregnancy
- Drug-Induced Hair Loss and Hair Growth
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Drug Reactions Affecting Hair: Diagnosis
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Update on the dermatologic use of systemic glucocorticosteroids
- Drug-Induced Hair Disorders
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Dermatoses of pregnancy
- Physiologic changes and dermatoses of pregnancy
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Comprehension Testing for OTC Drug Labels: Goals, Methods, Target Population, and Testing Environment
- New treatments for rheumatoid arthritis
- Women’s Health Considerations for Lipid Management
- Symptom management in inflammatory bowel disease
- Skin eruptions specific to pregnancy: an overview
- The spectrum of nephrocutaneous diseases and associations
- Women’s Health Considerations for Lipid Management